Results 241 to 250 of about 747,762 (279)

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Density-adjusted analysis of cell interactions to decipher tissue landscape changes. [PDF]

open access: yesiScience
Siddiqui M   +15 more
europepmc   +1 more source

Evapotranspiration Everywhere, All the Time: Towards a Unified View From Earth Observation. [PDF]

open access: yesGlob Chang Biol
Fisher JB   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy